A piece of news
Caixa Capital Risc and Kereon Partners have invested in this spin-off created through technology transfer from IDIBAPS-Hospital Clínic de Barcelona
Transplant Biomedicals, a spin-off of IDIBAPS-Hospital Clinic Barcelona, has received an injection of €2.5 millions led by Caixa Capital Risc and Kereon Partners to move into the clinical phase with its innovative medical device that will help preserve and transport organs for transplant, specifically livers and kidneys.
This is the most important round of funding to date for a non-diagnostic medical device company in Spain. Since 2014, Transplant Biomedicals, founded by Dr. Carmen Peralta and Ignasi Heras, has raised €3.5 million in venture capital.
In addition to studies with patients, the investment will cover technological development for the device and obtaining CE marking "to begin sales in Europe in 2018," says Ignasi Heras, CEO of the Barcelona-based company (it got its start in the Barcelona Science Park and is currently located in the Barcelona Activa’s Barcelona Nord Technology Park).
For more information, see the press release (in Catalan).